Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU庐 (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
FLORENCE, Italy & HONG KONG--(BUSINESS WIRE)--Nov 7, 2023--The Menarini Group (鈥淢enarini鈥), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. (鈥淪ciClone鈥), an international biopharmaceutical company, today announced ...
